Akcea Therapeutics, Inc.
(NASDAQ : AKCA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.35%140.450.6%$757.60m
PFEPfizer Inc.
0.84%43.370.9%$743.93m
MRKMerck & Co., Inc.
0.13%70.510.6%$456.94m
ABBVAbbVie, Inc.
0.56%95.902.1%$344.53m
LLYEli Lilly and Company
0.99%106.761.0%$323.11m
BMYBristol-Myers Squibb Company
0.26%61.461.4%$270.35m
AZNAstraZeneca PLC Sponsored ADR
-0.07%37.531.3%$130.99m
NVSNovartis AG Sponsored ADR
-0.18%84.980.2%$110.62m
GSKGlaxoSmithKline plc Sponsored ADR
0.57%39.440.2%$73.30m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.34%47.480.1%$52.56m
SNYSanofi Sponsored ADR
0.32%43.890.2%$44.27m
LCILannett Company, Inc.
-0.51%4.8837.0%$15.74m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.49%2.031.7%$0.13m
EPIXESSA Pharma Inc
-6.12%3.070.1%$0.05m

Company Profile

Akcea Therapeutics, Inc. is a late-stage pharmaceutical company, which engages in the development and commercializing of drugs fro the treatment of cardio metabolic diseases caused by lipid disorders. Its products include novel drugs under the followng brands: volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.